Clinical trial
Central Mechanisms and Treatment Response of Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
NCT03292458 is registered in ClinicalTrials.gov with Kristina Simonyan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Central Mechanisms and Treatment Response of Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
- Lead sponsor
- Kristina Simonyan
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 22, 2018
- Completion date
- October 11, 2024
- Enrollment
- 117 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spasmodic dysphonia, voice tremor